Cytokine Signalling Forum

Publications

Free summaries and slides for a selection of papers

The Steering Committee regularly select the most relevant and up-to-date publications for rapid review. This includes a brief summary highlighting the key points of the paper and a slide deck going into more detail of the data.

CME Courses

Free interactive tutorials, videos and assessments

A range of accredited distance learning programmes to meet the educational need of rheumatology specialists. Key topics of interest have been identified through consultation and guidance from our expert scientific steering committee.

Latest Podcasts

Author Interview: Professor Kevin Winthrop (December 2021)

Professor Kevin Winthrop, Professor of Medicine at Oregon Health & Science University.

23rd December 2021

Discussing Rheumatology: Safety of filgotinib, and tofacitinib in pJIA

Prof Iain McInnes reviews two papers this month, and discusses exposure-adjusted incidence rates of TEAEs and AESIs with filgotinib, as well as the efficacy and safety of tofacitinib in pJIA.

23rd December 2021

Author Interview: Professor Kevin Winthrop (November 2021)

Professor Kevin Winthrop, Professor of Medicine at Oregon Health & Science University.

22nd December 2021

Discussing Rheumatology: Risk of HZ with UPA, and JAKs in SpA

Prof Iain McInnes reviews two papers this month, and discusses the increased risk of HZ infection with upadacitinib, as well as the role of the JAK-STAT pathway in SpA pathenogenesis.

06th December 2021

Author Interview: Professor Atul Deodhar

Professor Atul Deodhar, professor of medicine at Oregon Health & Science University.

06th December 2021

Author Interview: Professor Roy Fleischmann

Professor Roy Fleishmann, clinical professor of medicine at the University of Texas Southwestern Medical Center.

18th November 2021

Discussing Rheumatology: Herpes Zoster and HBV

Prof Iain McInnes discusses the risk of herpes zoster in RA patients taking biologics and DMARDS. He also discusses reactivation of hepatitis B in patients with RA taking tofacitinib.

31st October 2021

Rheumatology Author Professor Paul Bird: Tofacitinib Effectiveness

Paul Bird, Conjoint Professor at the University of South Wales joins Professor Peter Nash, where he discusses real-world data of tofacitinib therapy in RA

15th October 2021

Discussing Rheumatology: Poor Prognostic Factors, Monotherapy, and Combination Therapy

Prof Iain McInnes discusses poor prognostics factors from the FINCH 3 study, and the effectiveness and persistence of monotherapy and combination therapy from the Australian OPAL study.

23rd September 2021